els2022finelib

Publisher

Elsevier
Agreement ID els2022finelib
Agreement labeling Elsevier Cell Press Read & Publish
Has the agreement been fully disclosed and published? Yes
URL https://finelib.fi/cell-press-agreement/
Agreement period 01/01/2022 – 12/31/2024
Consortia / Institution FinELib consortium
Country Finland
SIZE

Approximate range of annual corresponding author publications

 30
Comments on size/article output The agreement covers Cell Press hybrid journals. The yearly allowance makes up around 100% of the output. The allowance will increase gradually during the agreement term.
COSTS

How do the costs of the agreement relate to previous subscription-only agreements with the publisher?

 Cost increase
Comments on cost development Taking into account the fees previously paid to the Publisher for subscription as well as for OA publishing (APCs)
FINANCIAL SHIFT

Transformative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?

 Subscriptions partly converted to OA publishing fees
OA COVERAGE

Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?

 Yes
Are fully open access journals covered by the agreement? No
OA LICENSE CC-BY preference, exceptions allowed
ARTICLE TYPES
 Original research articles
Review articles
Case reports, Short communications, Short reviews (surveys), Original software publications, Data articles, Micro-articles, Replication studies, Videos, Protocols
ACCESS COSTS

What is the approximate share of access related costs of the overall agreement?

 More than 50%
ACCESS COVERAGE

Are all read relevant journals covered by the agreement?

 Yes
PERPETUAL ACCESS RIGHTS Yes
WORKFLOW ASSESSMENT Too early to assess
Request contact to the licensee contact [at] esac-initiative [dot] org